Mumbai based pharma company Lupin says any kind of price control will be a deterrent for the industry and 30 percent of its portfolio will be impacted if government implements price control measures.
first published: Nov 21, 2012 11:35 am
A collection of the most-viewed Moneycontrol videos.
Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell
Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more
How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
